Physician profile
Jacob Friedman
NPI 1922000561
$2,224.95
in general payments reported to CMS, 2019-2025
14 companies · $89.53 in 2025
The $89.53 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $924 · 2020: $894 · 2021: $13.36 · 2022: $24.27 · 2023: $194 · 2024: $85.64 · 2025: $89.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $756.93 | 2020 | |
| Stryker Corporation | $740.75 | 2019-2021 | |
| Peerless Surgical INC. | $148.40 | 2019-2025 | |
| Smith+Nephew, INC. | $109.03 | 2019-2025 | Legion, Journey II |
| Bioventus LLC | $108.99 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Arthrex, INC. | $84.41 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $57.88 | 2023-2024 | Iovera, Zilretta, Exparel |
| Depuy Synthes Sales INC. | $50.26 | 2023 | Vapr |
| Molnlycke Health Care US, LLC | $49.01 | 2023 | Mlnlycke Z-Flex Fluidized Heel Boot, Mepilex Transfer Ag, Mepiform |
| Ermi LLC | $39.24 | 2023 | |
| Ethicon US, LLC | $31.71 | 2025 | Dermabond Prineo, Vistaseal |
| Orthofix Medical, INC. | $19.41 | 2023 | Physio-Stim |
| Avanos Medical | $16.57 | 2019 | |
| Abbott Laboratories | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.